Yuri Serna

TILs Plus Pembro Show Efficacy in GI Cancers

April 22, 2025

Neoantigen-specific tumor-infiltrating lymphocytes (TILs) plus pembrolizumab demonstrate efficacy against treatment-refractory gastrointestinal (GI) cancers in early results from a phase 2...

Yuri Serna

TILs Plus Pembro Show Efficacy in GI Cancers

What’s that rash? Put some thought into asking Google for medical help

‘No-touch’ vein harvesting has meaningful benefits for heart bypass patients, finds study

Gabapentinoids unlikely to be directly linked to self-harm risk, study finds

Novel breath test shows promise for diagnosing and monitoring bacterial infections

So You Lost Your Contact Lens in Your Eye. Here’s Exactly What to Do

Dr. Kuri & Associates Responds to Semaglutide Shortage with Price Reduction on Gastric Sleeve Surgery & Lap-Band Revision Surgery

Meet the Married Couple Who Both Work as Hollywood Intimacy Coordinators

Judge Blocks Trump’s Order Curtailing Youth Gender-Affirming Care

To the Pandemic Czar: Are We Prepared to Talk About Bird Flu?

Advancing stroke imaging analysis with interpretable AI and effective connectivity models

What’s that rash? Put some thought into asking Google for medical help

‘No-touch’ vein harvesting has meaningful benefits for heart bypass patients, finds study

Gabapentinoids unlikely to be directly linked to self-harm risk, study finds

Novel breath test shows promise for diagnosing and monitoring bacterial infections

So You Lost Your Contact Lens in Your Eye. Here’s Exactly What to Do

About PhaMed

Recent News

You may have missed

About PhaMed

Recent News

Categories